Table of contents
Volume 88, Issue 6
Published online 18 March 2003 (803-982)
Clinical |
Molecular and Cellular Pathology |
Genetics and Genomics |
Experimental Therapeutics |
Letters to the Editor
Minireview
Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy FREE
P Ricchi, R Zarrilli, A di Palma and A M Acquaviva
Br J Cancer 88: 803-807; doi:10.1038/sj.bjc.6600829
Clinical
Phase I/II trial of weekly cisplatin, etoposide, and irinotecan chemotherapy for metastatic lung cancer: JCOG 9507 FREE
I Sekine, Y Nishiwaki, R Kakinuma, K Kubota, F Hojo, T Matsumoto, H Ohmatsu, K Goto, T Kodama, K Eguchi, T Shinkai, T Tamura, Y Ohe, H Kunitoh, K Yoshimura and N Saijo
Br J Cancer 88: 808-813; doi:10.1038/sj.bjc.6600800
Adaptive intrapatient dose escalation of cisplatin in combination with low-dose vp16 in patients with nonsmall cell lung cancer FREE
J H M Schellens, A S Th Planting, N van Zandwijk, J Ma, M Maliepaard, M E L van der Burg, M de Boer-Dennert, E Brouwer, A van der Gaast, M J van den Bent and J Verweij
Br J Cancer 88: 814-821; doi:10.1038/sj.bjc.6600794
An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer FREE
M J Drake, W Robson, P Mehta, I Schofield, D E Neal and H Y Leung
Br J Cancer 88: 822-827; doi:10.1038/sj.bjc.6600817
Radiotherapy with 16 Gy may fail to eradicate testicular intraepithelial neoplasia: preliminary communication of a dose-reduction trial of the German Testicular Cancer Study Group FREE
J Classen, K Dieckmann, M Bamberg, R Souchon, S Kliesch, M Kuehn and V Loy
Br J Cancer 88: 828-831; doi:10.1038/sj.bjc.6600771
Stage of breast cancer at diagnosis among women with cosmetic breast implants FREE
L R Hölmich, L Mellemkjær, K A Gunnarsdóttir, U B Tange, C Krag, S Møller, J K McLaughlin and J H Olsen
Br J Cancer 88: 832-838; doi:10.1038/sj.bjc.6600819
How doctors record breaking bad news in ovarian cancer FREE
J M Kirwan, D G Tincello, T Lavender and R E Kingston
Br J Cancer 88: 839-842; doi:10.1038/sj.bjc.6600816
Molecular and Cellular Pathology
External validity of a prediction rule for residual mass histology in testicular cancer: an evaluation for good prognosis patients FREE
Y Vergouwe, E W Steyerberg, R de Wit, J T Roberts, H J Keizer, L Collette, S P Stenning and J D F Habbema
Br J Cancer 88: 843-847; doi:10.1038/sj.bjc.6600759
Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen FREE
J Kupryja
czyk, T Szymaska, R M
dry, A Timorek, J Stelmachów, G Karpiska, A Rembiszewska, I Zió
kowska, E Kraszewska, J D
bniak, J Emerich, M Uaska, A Pu
aska, M Jdryka, M Goluda, A Chudecka-Gaz, I Rzepka-Górska, M Klimek, K Urbaski, J Brborowicz, J Zieliski and J Markowska
Br J Cancer 88: 848-854; doi:10.1038/sj.bjc.6600789
Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3 FREE
I Vande Broek, K Asosingh, K Vanderkerken, N Straetmans, B Van Camp and I Van Riet
Br J Cancer 88: 855-862; doi:10.1038/sj.bjc.6600833
Prognostic value of maspin mRNA expression in ER
-positive postmenopausal breast carcinomas FREE
I Bièche, I Girault, J-C Sabourin, S Tozlu, K Driouch, M Vidaud and R Lidereau
Br J Cancer 88: 863-870; doi:10.1038/sj.bjc.6600812
Elevated expression and altered processing of fibulin-1 protein in human breast cancer FREE
L M Greene, W O Twal, M J Duffy, E W McDermott, A D Hill, N J O'Higgins, A H McCann, P A Dervan, W S Argraves and W M Gallagher
Br J Cancer 88: 871-878; doi:10.1038/sj.bjc.6600802
Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours FREE
A J Zurita, J E Diestra, E Condom, X García del Muro, G L Scheffer, R J Scheper, J Pérez, J R Germà-Lluch and M A Izquierdo
Br J Cancer 88: 879-886; doi:10.1038/sj.bjc.6600803
L523S, an RNA-binding protein as a potential therapeutic target for lung cancer FREE
T Wang, L Fan, Y Watanabe, P D McNeill, G G Moulton, C Bangur, G R Fanger, M Okada, Y Inoue, D H Persing and S G Reed
Br J Cancer 88: 887-894; doi:10.1038/sj.bjc.6600806
Detection of replicative integrity in small colonic biopsies using the BrdUrd comet assay FREE
A P McGlynn, G R Wasson, S O'Reilly, V J McKelvey-Martin, H McNulty, J J Strain, G McKerr, F Mullan, N Mahmud, J Scott, D G Weir and C S Downes
Br J Cancer 88: 895-901; doi:10.1038/sj.bjc.6600836
Antiapoptotic effect of haem oxygenase-1 induced by nitric oxide in experimental solid tumour FREE
S Tanaka, T Akaike, J Fang, T Beppu, M Ogawa, F Tamura, Y Miyamoto and H Maeda
Br J Cancer 88: 902-909; doi:10.1038/sj.bjc.6600830
Genetics and Genomics
Functional screening of genes suppressing TRAIL-induced apoptosis: distinct inhibitory activities of Bcl-XL and Bcl-2 FREE
I-K Kim, Y-K Jung, D-Y Noh, Y-S Song, C-H Choi, B-H Oh, E S Masuda and Y-K Jung
Br J Cancer 88: 910-917; doi:10.1038/sj.bjc.6600795
TRAIL-
and TRAIL-
: two novel splice variants of the human TNF-related apoptosis-inducing ligand (TRAIL) without apoptotic potential FREE
A Krieg, T Krieg, M Wenzel, M Schmitt, U Ramp, B Fang, H E Gabbert, C D Gerharz and C Mahotka
Br J Cancer 88: 918-927; doi:10.1038/sj.bjc.6600772
CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia FREE
M T Tayeb, C Clark, N E Haites, L Sharp, G I Murray and H L McLeod
Br J Cancer 88: 928-932; doi:10.1038/sj.bjc.6600825
CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status FREE
K Gudmundsdottir, S Thorlacius, J G Jonasson, B F Sigfusson, L Tryggvadottir and J E Eyfjord
Br J Cancer 88: 933-936; doi:10.1038/sj.bjc.6600839
Experimental Therapeutics
A33scFv–cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapy FREE
P M Deckert, C Renner, L S Cohen, A Jungbluth, G Ritter, J R Bertino, L J Old and S Welt
Br J Cancer 88: 937-939; doi:10.1038/sj.bjc.6600751
Tumoricidal activity of lauryl gallate towards chemically induced skin tumours in mice FREE
E Ortega, M C Sadaba, A I Ortiz, C Cespon, A Rocamora, J M Escolano, G Roy, L M Villar and P Gonzalez-Porque
Br J Cancer 88: 940-943; doi:10.1038/sj.bjc.6600805
Preclinical studies of targeted therapy for breast cancer using 213Bi-labelled-plasminogen activator inhibitor type 2 FREE
B J Allen, Z Tian, S M A Rizvi, Y Li and M Ranson
Br J Cancer 88: 944-950; doi:10.1038/sj.bjc.6600838
Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell lines FREE
S Okuno, H Sato, K Kuriyama-Matsumura, M Tamba, H Wang, S Sohda, H Hamada, H Yoshikawa, T Kondo and S Bannai
Br J Cancer 88: 951-956; doi:10.1038/sj.bjc.6600786
Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity FREE
M de Bruin, T van Capel, K Van der Born, F A Kruyt, M Fukushima, K Hoekman, H M Pinedo and G J Peters
Br J Cancer 88: 957-964; doi:10.1038/sj.bjc.6600808
IDN 5390: an oral taxane candidate for protracted treatment schedules FREE
G Pratesi, D Laccabue, C Lanzi, G Cassinelli, R Supino, M Zucchetti, R Frapolli, M D'Incalci, E Bombardelli, P Morazzoni, A Riva and F Zunino
Br J Cancer 88: 965-972; doi:10.1038/sj.bjc.6600784
Reversal of Taxol resistance in hepatoma by cyclosporin A: involvement of the PI-3 kinase-AKT 1 pathway FREE
H-L Lin, W-Y Lui, T-Y Liu and C-W Chi
Br J Cancer 88: 973-980; doi:10.1038/sj.bjc.6600788
Letters to the Editor
Value of tyrosinase RNA detection by an RT–PCR method in melanoma prognosis FREE
K Konstantopoulos
Br J Cancer 88: 981; doi:10.1038/sj.bjc.6600834
Reply: Value of tyrosinase RT–PCR in melanoma prognosis FREE
H Gogas
Br J Cancer 88: 982; doi:10.1038/sj.bjc.6600835
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
